Osteoporosis Management in the Era of COVID-19.
J Bone Miner Res. 2020 May 14;: Authors: Yu EW, Tsourdi E, Clarke BL, Bauer DC, Drake MT
Osteoporosis is a chronic condition which reflects reduced bone strength and an associated increased risk for fracture. As a chronic condition, osteoporosis generally requires sustained medical intervention(s) to limit the risks for additional bone loss, compromise of skeletal integrity, and fracture occurrence. Further complicating this issue is the fact that the abrupt cessation of some therapies can be associated with an increased risk for harm. It is in this context that the COVID-19 pandemic has brought unprecedented disruption to the provision of healthcare globally, including near universal requirements for social distancing. In this Perspective, we provide evidence, where available, regarding the general care of patients with osteoporosis in the COVID-19 era, and provide clinical recommendations based primarily on expert opinion when data is absent. Particular emphasis is placed on the transition from parenteral osteoporosis therapies. It is hoped that these recommendations can be used to safely guide care for patients with osteoporosis until a return to routine clinical care standards is available. PMID: 32406536 [PubMed - as supplied by publisher]